Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Teva
Fish and Richardson
AstraZeneca
Mallinckrodt
Johnson and Johnson
US Department of Justice
Chinese Patent Office
Express Scripts
Harvard Business School

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087211

« Back to Dashboard

NDA 087211 describes METHOCARBAMOL AND ASPIRIN, which is a drug marketed by Ivax Sub Teva Pharms, Mcneil, Par Pharm, and Stevens J, and is included in four NDAs. Additional details are available on the METHOCARBAMOL AND ASPIRIN profile page.

The generic ingredient in METHOCARBAMOL AND ASPIRIN is aspirin; methocarbamol. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; methocarbamol profile page.
Summary for 087211
Tradename:METHOCARBAMOL AND ASPIRIN
Applicant:Ivax Sub Teva Pharms
Ingredient:aspirin; methocarbamol
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength325MG;400MG
Approval Date:Dec 22, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Healthtrust
Cantor Fitzgerald
Colorcon
Chinese Patent Office
UBS
Julphar
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot